Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$27,000.00

Multi-omic Profiling of Extracellular Vesicles in Leiomyosarcoma

FY 2024-25

Summary
Liquid biopsy is a non-invasive method for detecting tumor-derived analytes, such as circulating tumor cells, circulating tumor DNA, proteins, and extracellular vesicles present in the body fluids of cancer patients. Circulating tumor cells, proteins, and circulating tumor DNA are extensively studied and approved for testing in clinical practice. Yet another analyte for liquid biopsy studies are extracellular vesicles (EVs) – secretory vesicles which carry various molecules (nucleic acids, proteins, lipids). Tumor EVs can be uptaken by healthy cells, promoting tumor dissemination. Thus, tumor EVs may inform diagnosis and prognosis and contribute to metastasis. While tumor EVs have been studied in various cancers, their role in leiomyosarcoma (LMS) – frequently metastasizing malignant tumor of smooth muscle differentiation associated with poor outcome – remains unexplored. We hypothesize that by studying LMS-derived EVs, we will discover currently unknown pathological processes contributing to LMS metastasis. In this study, we will examine EVs released from LMS cells, leiomyoma (LM) cells – benign counterpart of LMS, and from plasma samples of patients with LMS, LM, and healthy donors. We will isolate EVs using ultracentrifugation and Size-Exclusion Chromatography. We will measure the size and number of EVs, and we will detect EV- and LMS-specific markers using Western blot. We will study the DNA and proteins in EVs using shallow whole genome sequencing and mass spectrometry, respectively. These experiments will reveal biomarkers and molecular processes associated with metastasis in LMS. This study will provide knowledge that will contribute to the development of blood-based liquid biopsy tests for improved diagnosis and prediction of metastasis in LMS patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
531668
Name
Markarian Pateel
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Multi-omic Profiling of Extracellular Vesicles in Leiomyosarcoma
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Extracellular Vesicles; Genomics; Leiomyosarcoma; Liquid Biopsy; Metastasis; Molecular Oncology; Sarcoma
Abstract
Liquid biopsy is a non-invasive method for detecting tumor-derived analytes, such as circulating tumor cells, circulating tumor DNA, proteins, and extracellular vesicles present in the body fluids of cancer patients. Circulating tumor cells, proteins, and circulating tumor DNA are extensively studied and approved for testing in clinical practice. Yet another analyte for liquid biopsy studies are extracellular vesicles (EVs) – secretory vesicles which carry various molecules (nucleic acids, proteins, lipids). Tumor EVs can be uptaken by healthy cells, promoting tumor dissemination. Thus, tumor EVs may inform diagnosis and prognosis and contribute to metastasis. While tumor EVs have been studied in various cancers, their role in leiomyosarcoma (LMS) – frequently metastasizing malignant tumor of smooth muscle differentiation associated with poor outcome – remains unexplored. We hypothesize that by studying LMS-derived EVs, we will discover currently unknown pathological processes contributing to LMS metastasis. In this study, we will examine EVs released from LMS cells, leiomyoma (LM) cells – benign counterpart of LMS, and from plasma samples of patients with LMS, LM, and healthy donors. We will isolate EVs using ultracentrifugation and Size-Exclusion Chromatography. We will measure the size and number of EVs, and we will detect EV- and LMS-specific markers using Western blot. We will study the DNA and proteins in EVs using shallow whole genome sequencing and mass spectrometry, respectively. These experiments will reveal biomarkers and molecular processes associated with metastasis in LMS. This study will provide knowledge that will contribute to the development of blood-based liquid biopsy tests for improved diagnosis and prediction of metastasis in LMS patients.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Markarian, Pateel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~